1440 related articles for article (PubMed ID: 32979938)
1. Evasion of Type I Interferon by SARS-CoV-2.
Xia H; Cao Z; Xie X; Zhang X; Chen JY; Wang H; Menachery VD; Rajsbaum R; Shi PY
Cell Rep; 2020 Oct; 33(1):108234. PubMed ID: 32979938
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 Nonstructural Protein 1 Inhibits the Interferon Response by Causing Depletion of Key Host Signaling Factors.
Kumar A; Ishida R; Strilets T; Cole J; Lopez-Orozco J; Fayad N; Felix-Lopez A; Elaish M; Evseev D; Magor KE; Mahal LK; Nagata LP; Evans DH; Hobman TC
J Virol; 2021 Jun; 95(13):e0026621. PubMed ID: 34110264
[TBL] [Abstract][Full Text] [Related]
3. Activation and evasion of type I interferon responses by SARS-CoV-2.
Lei X; Dong X; Ma R; Wang W; Xiao X; Tian Z; Wang C; Wang Y; Li L; Ren L; Guo F; Zhao Z; Zhou Z; Xiang Z; Wang J
Nat Commun; 2020 Jul; 11(1):3810. PubMed ID: 32733001
[TBL] [Abstract][Full Text] [Related]
4. Roles and functions of SARS-CoV-2 proteins in host immune evasion.
Rashid F; Xie Z; Suleman M; Shah A; Khan S; Luo S
Front Immunol; 2022; 13():940756. PubMed ID: 36003396
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists.
Yuen CK; Lam JY; Wong WM; Mak LF; Wang X; Chu H; Cai JP; Jin DY; To KK; Chan JF; Yuen KY; Kok KH
Emerg Microbes Infect; 2020 Dec; 9(1):1418-1428. PubMed ID: 32529952
[TBL] [Abstract][Full Text] [Related]
6. Middle East respiratory syndrome coronavirus M protein suppresses type I interferon expression through the inhibition of TBK1-dependent phosphorylation of IRF3.
Lui PY; Wong LY; Fung CL; Siu KL; Yeung ML; Yuen KS; Chan CP; Woo PC; Yuen KY; Jin DY
Emerg Microbes Infect; 2016 Apr; 5(4):e39. PubMed ID: 27094905
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 NSP13 Inhibits Type I IFN Production by Degradation of TBK1 via p62-Dependent Selective Autophagy.
Sui C; Xiao T; Zhang S; Zeng H; Zheng Y; Liu B; Xu G; Gao C; Zhang Z
J Immunol; 2022 Feb; 208(3):753-761. PubMed ID: 34996837
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the IFN-α JAK/STAT Pathway by MERS-CoV and SARS-CoV-1 Proteins in Human Epithelial Cells.
Zhang Y; Gargan S; Roche FM; Frieman M; Stevenson NJ
Viruses; 2022 Mar; 14(4):. PubMed ID: 35458397
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 ORF6 protein does not antagonize interferon signaling in respiratory epithelial Calu-3 cells during infection.
Li M; Ayyanathan K; Dittmar M; Miller J; Tapescu I; Lee JS; McGrath ME; Xue Y; Vashee S; Schultz DC; Frieman MB; Cherry S
mBio; 2023 Aug; 14(4):e0119423. PubMed ID: 37377442
[TBL] [Abstract][Full Text] [Related]
10. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Membrane (M) and Spike (S) Proteins Antagonize Host Type I Interferon Response.
Zhang Q; Chen Z; Huang C; Sun J; Xue M; Feng T; Pan W; Wang K; Dai J
Front Cell Infect Microbiol; 2021; 11():766922. PubMed ID: 34950606
[TBL] [Abstract][Full Text] [Related]
11. Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2.
Thoms M; Buschauer R; Ameismeier M; Koepke L; Denk T; Hirschenberger M; Kratzat H; Hayn M; Mackens-Kiani T; Cheng J; Straub JH; Stürzel CM; Fröhlich T; Berninghausen O; Becker T; Kirchhoff F; Sparrer KMJ; Beckmann R
Science; 2020 Sep; 369(6508):1249-1255. PubMed ID: 32680882
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 Nucleocapsid Protein Targets RIG-I-Like Receptor Pathways to Inhibit the Induction of Interferon Response.
Oh SJ; Shin OS
Cells; 2021 Mar; 10(3):. PubMed ID: 33801464
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 NSP13 interacts with host IRF3, blocking antiviral immune responses.
Feng K; Zhang HJ; Min YQ; Zhou M; Deng F; Wang HL; Li PQ; Ning YJ
J Med Virol; 2023 Jun; 95(6):e28881. PubMed ID: 37314155
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 viral proteins NSP1 and NSP13 inhibit interferon activation through distinct mechanisms.
Vazquez C; Swanson SE; Negatu SG; Dittmar M; Miller J; Ramage HR; Cherry S; Jurado KA
PLoS One; 2021; 16(6):e0253089. PubMed ID: 34166398
[TBL] [Abstract][Full Text] [Related]
15. Middle East respiratory syndrome coronavirus ORF4b protein inhibits type I interferon production through both cytoplasmic and nuclear targets.
Yang Y; Ye F; Zhu N; Wang W; Deng Y; Zhao Z; Tan W
Sci Rep; 2015 Dec; 5():17554. PubMed ID: 26631542
[TBL] [Abstract][Full Text] [Related]
16. SARS-Coronavirus-2 Nsp13 Possesses NTPase and RNA Helicase Activities That Can Be Inhibited by Bismuth Salts.
Shu T; Huang M; Wu D; Ren Y; Zhang X; Han Y; Mu J; Wang R; Qiu Y; Zhang DY; Zhou X
Virol Sin; 2020 Jun; 35(3):321-329. PubMed ID: 32500504
[TBL] [Abstract][Full Text] [Related]
17. Middle East Respiratory Syndrome Coronavirus NS4b Protein Inhibits Host RNase L Activation.
Thornbrough JM; Jha BK; Yount B; Goldstein SA; Li Y; Elliott R; Sims AC; Baric RS; Silverman RH; Weiss SR
mBio; 2016 Mar; 7(2):e00258. PubMed ID: 27025250
[TBL] [Abstract][Full Text] [Related]
18. Interplay between SARS-CoV-2 and the type I interferon response.
Sa Ribero M; Jouvenet N; Dreux M; Nisole S
PLoS Pathog; 2020 Jul; 16(7):e1008737. PubMed ID: 32726355
[TBL] [Abstract][Full Text] [Related]
19. Type I and Type III Interferons - Induction, Signaling, Evasion, and Application to Combat COVID-19.
Park A; Iwasaki A
Cell Host Microbe; 2020 Jun; 27(6):870-878. PubMed ID: 32464097
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 ORF6 disrupts nucleocytoplasmic trafficking to advance viral replication.
Miyamoto Y; Itoh Y; Suzuki T; Tanaka T; Sakai Y; Koido M; Hata C; Wang CX; Otani M; Moriishi K; Tachibana T; Kamatani Y; Yoneda Y; Okamoto T; Oka M
Commun Biol; 2022 May; 5(1):483. PubMed ID: 35590097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
